Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica C Hassel

Showing results (81-90 of 272) with videos related to

Pageof 28
Sort By:
Cancer Immunology, Immunotherapy : CII|March 9, 2018
Rituximab as a therapeutic option for patients with advanced melanomaJulia K Winkler, Matthias Schiller, Carolin Bender, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 26, 2023
The prognostic value of [<sup>18</sup>F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteriaChristos Sachpekidis, Vivienn Weru, Annette Kopp-Schneider, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2026
Are liver metastases from uveal melanoma a clinical indication for dynamic PET? A comparison of Patlak parametric imaging with standard and delayed static SUV imaging using long axial field-of-view PET/CTLeyun Pan, Christos Sachpekidis, Dimitrios S Strauss, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 13, 2022
Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapyMartin Salzmann, Klaus Hess, Kristin Lang, et al.
The Journal of Prosthetic Dentistry|February 12, 2008
Predicting tooth color from facial features and gender: results from a white elderly cohortAlexander J Hassel, Ina Nitschke, Jens Dreyhaupt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 1, 2014
Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing studyChristos Sachpekidis, Lionel Larribere, Leyun Pan, et al.
Melanoma Research|January 18, 2019
18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumabChristos Sachpekidis, Annette Kopp-Schneider, Lara Hakim-Meibodi, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 16, 2007
Treatment of ear keloids by compression, using a modified oyster-splint techniqueJessica C Hassel, Barbara Roberg, Alexander Kreuter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2022
Application of the long axial field-of-view PET/CT with low-dose [<sup>18</sup>F]FDG in melanomaChristos Sachpekidis, Leyun Pan, Annette Kopp-Schneider, et al.
Acta Dermato-Venereologica|November 22, 2016
PD-1 Antibody-induced Guillain-Barré Syndrome in a Patient with Metastatic MelanomaRoland Schneiderbauer, Malessa Schneiderbauer, Wolfgang Wick, et al.
Pageof 28

Showing results (81-90 of 272) with videos related to

Sort By:
Pageof 28
Cancer Immunology, Immunotherapy : CII|March 9, 2018
Rituximab as a therapeutic option for patients with advanced melanomaJulia K Winkler, Matthias Schiller, Carolin Bender, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 26, 2023
The prognostic value of [<sup>18</sup>F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteriaChristos Sachpekidis, Vivienn Weru, Annette Kopp-Schneider, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2026
Are liver metastases from uveal melanoma a clinical indication for dynamic PET? A comparison of Patlak parametric imaging with standard and delayed static SUV imaging using long axial field-of-view PET/CTLeyun Pan, Christos Sachpekidis, Dimitrios S Strauss, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 13, 2022
Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapyMartin Salzmann, Klaus Hess, Kristin Lang, et al.
The Journal of Prosthetic Dentistry|February 12, 2008
Predicting tooth color from facial features and gender: results from a white elderly cohortAlexander J Hassel, Ina Nitschke, Jens Dreyhaupt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 1, 2014
Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing studyChristos Sachpekidis, Lionel Larribere, Leyun Pan, et al.
Melanoma Research|January 18, 2019
18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumabChristos Sachpekidis, Annette Kopp-Schneider, Lara Hakim-Meibodi, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 16, 2007
Treatment of ear keloids by compression, using a modified oyster-splint techniqueJessica C Hassel, Barbara Roberg, Alexander Kreuter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2022
Application of the long axial field-of-view PET/CT with low-dose [<sup>18</sup>F]FDG in melanomaChristos Sachpekidis, Leyun Pan, Annette Kopp-Schneider, et al.
Acta Dermato-Venereologica|November 22, 2016
PD-1 Antibody-induced Guillain-Barré Syndrome in a Patient with Metastatic MelanomaRoland Schneiderbauer, Malessa Schneiderbauer, Wolfgang Wick, et al.
Pageof 28